Tamoxifen inducing differentiation of oligodendrocyte lineage cells in the central nervous system 

XU Ting Lü Hai-yan YU Qing-ting YANG Zui-su YUAN Fa-lei

Acta Anatomica Sinica ›› 2024, Vol. 55 ›› Issue (6) : 685-692.

PDF(6687 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(6687 KB)
Acta Anatomica Sinica ›› 2024, Vol. 55 ›› Issue (6) : 685-692. DOI: 10.16098/j.issn.0529-1356.2024.06.005
Neurobiology

Tamoxifen inducing differentiation of oligodendrocyte lineage cells in the central nervous system 

  • XU  Ting1  Lü  Hai-yan2  YU  Qing-ting1  YANG  Zui-su1  YUAN  Fa-lei1*  #br#
Author information +
History +

Abstract

Objective To investigate the differentiation of oligodendrocyte precursor cells after neural injury utilizing Sox10 cell lineage tracing in the cortical tissue. Methods  C57BL/6 mice and Sox10-CreERT2/red fluorescent protein(RFP) model mice were used in the current study. The Sox10-CreERT2/RFP model mice generated by crossing Sox10-CreERT2 and Ai9 were 8-week-old F1 mice (n =16), which were randomly divided into control group (n =4) and 7 days (n =4), 14 days (n =4), and 30 days feed groups (n =4). Tamoxifen(TAM) was used to induce the expression of RFP. The control group received tamoxifen dissolved in sunflower seed oil by gavage (40 mg/kg once daily for three consecutive days) and the brain tissues were obtained after 4 days. The feed group mice were fed with tamoxifen-containing feed to induce RFP expression, and the brain tissues were obtained after 7, 14, and 30 days, respectively. Immunofluorescent staining was performed to detect the expressions of neuronal nuclei (NeuN), microtubuleassociated protein 2 (MAP2), phosphorylated histone 2AX (γ-H2AX), cluster of differentiation 13 (CD13), γaminobutyric acid (GABA), glial fibrillary acidic protein (GFAP), cluster of differentiation 11b (CD11b), vesicular glutamate transporter 2 (VGLUT2), and adenomatous polyposis coli (APC, CC-1) in the brains of each group mice. The number of positive cells was counted, and the proportion was calculated. Eight-week-old male C57BL/6 mice were randomly divided into wild type(WT) group (n =4) and WT+TAM group (n =4). They were fed with regular feed and tamoxifencontaining feed for 30 days, respectively, and then brain tissues were obtained. Immunofluorescent double-labeling was used to detect the expressions of γ-H2AX positive neurons in the cortex of mice in both groups.   Results  In the control group, feed 7 days,14 days, and 30 days groups, the proportions of RFP+ pericytes among all RFP+ cells in the cortical tissue were (0.8±0.1)%, (2.7±0.1)%, (3.2±0.1)%, (4.0 ±0.1)%, respectively, and the proportion of mature oligodendrocytes (CC-1+ RFP+) in the feed 7 days group was (51.2±0.7)%. The proportions of RFPpositive neurons in the cortex after 14 and 30 days of tamoxifen feed were (0.7±0.1)% and (1.5±0.1)%, respectively, while no conversion to RFP-positive neurons was observed in the gavage group and 7 days feed group. RFP cells in the cortex of the 7 days or 30 days feed group did not express GFAP or CD11b. Extensive γ-H2AX+ NeuN+ staining was observed in the WT group and WT+TAM group. Conclusion  Long-term administration of tamoxifen can promote the differentiation of Sox10 cells into pericytes and neurons. Further investigation into the role of OPC in the neurovascular unit repair mechanism may contribute to a better understanding of the pathogenesis underlying AD. 

Key words

Tamoxifen / Oligodendrocyte lineage cell / Pericyte / Neuron / Sox10 / Immunofluorescence / Mouse

Cite this article

Download Citations
XU Ting Lü Hai-yan YU Qing-ting YANG Zui-su YUAN Fa-lei. Tamoxifen inducing differentiation of oligodendrocyte lineage cells in the central nervous system [J]. Acta Anatomica Sinica. 2024, 55(6): 685-692 https://doi.org/10.16098/j.issn.0529-1356.2024.06.005

References

  [1] Chen  JF, Wang F, Huang NX, et al. Oligodendrocytes and myelin: active players in neurodegenerative brains[J]? Dev Neurobiol, 2022, 82(2):160-174.
  [2] Toledo  JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre[J]. Brain, 2013, 136(Pt 9):2697-2706.
  [3] Feil  S, Valtcheva N, Feil R. Inducible Cre mice[J]. Methods Mol Biol, 2009, 530:343-363.
  [4] Sweeney  MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders[J]. Nat Rev Neurol, 2018, 14(3):133-150.
  [5] Depp  C, Sun T, Sasmita AO, et al. Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease[J].Nature,2023,618(7964):349-357.
  [6] Montagne  A, Nation DA, Sagare AP, et al. APOE4 leads to bloo-brain barrier dysfunction predicting cognitive decline[J]. Nature, 2020, 581(7806):71-76.
  [7] Denk  F, Ramer LM, Erskine EL, et al. Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis[J]. Acta Neuropathol Commun, 2015, 3:74.
  [8] Chen  X, Li J, Chen J, et al. Decision-making impairments in breast cancer patients treated with tamoxifen[J]. Horm Behav, 2014, 66(2):449-456.
  [9] Bender  CM, Paraska KK, Sereika SM, et al. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review[J]. J Pain Symptom Manage, 2001, 21(5):407-424.
  [10] Tomassy  GS, Berger DR, Chen HH, et al. Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex[J]. Science, 2014, 344(6181):319-324.
  [11] Dimou  L, Simon C, Kirchhoff F, et al. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex[J]. J Neurosci, 2008, 28(41):10434-10442.
  [12] Marques  S, Zeisel A, Codeluppi S, et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system[J]. Science, 2016, 352(6291):1326-1329.
  [13] Jung  B, Arnold TD, Raschperger E, et al. Visualization of vascular mural cells in developing brain using genetically labeled transgenic reporter mice[J]. J Cereb Blood Flow Metab, 2018, 38(3):456-468.
  [14] Rivers  LE, Young KM, Rizzi M, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice[J]. Nat Neurosci, 2008, 11(12):1392-1401.
  [15] Kuhlbrodt  K, Herbarth B, Sock E, et al. Sox10, a novel transcriptional modulator in glial cells[J]. J Neurosci, 1998, 18(1):237-250.
  [16] Zhang  Y, Li B, Cananzi S, et al. A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum[J]. Proc Natl Acad Sci U S A, 2022, 119(11):e2107339119.
  [17] Alikunju  S, Abdul Muneer PM, Zhang Y, et al. The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components[J]. Brain Behav Immun, 2011, 25(Suppl 1):S129-136.
  [18] Nikolakopoulou  AM, Montagne A, Kisler K, et al. Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss[J]. Nat Neurosci, 2019, 22(7):1089-1098.
  [19] Montagne  A, Nikolakopoulou AM, Zhao Z, et al. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system[J]. Nat Med, 2018, 24(3):326-337.
  [20] Armulik  A, Genov G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises[J]. Dev Cell, 2011, 21(2):193-215.
  [21] Kr?mer-Albers EM, Werner HB. Mechanisms of axonal support by oligodendrocyte-derived extracellular vesicles[J]. Nat Rev Neurosci, 2023, 24(8):474-486.
  [22] Wang  LL, Serrano C, Zhong X, et al. Revisiting astrocyte to neuron conversion with lineage tracing in vivo[J]. Cell, 2021, 184(21):5465-5481.e5416.
  [23] Salinas  Tejedor L, Gudi V, Kucman V, et al. Oligodendroglial markers in the cuprizone model of CNS de- and remyelination[J]. HistolHistopathol, 2015, 30(12):1455-1464.
  [24] Jorstad  NL, Wilken MS, Grimes WN, et al. Stimulation of functional neuronal regeneration from Müller glia in adult mice[J]. Nature, 2017, 548(7665):103-107.
  [25] Hao  Z, Xu J, Zhao H, et al. The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation[J]. BMC PharmacolToxicol, 2022, 23(1):33.
  [26] Cortes  E, Lachowski D, Rice A, et al. Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor[J]. Oncogene, 2019, 38(16):2910-2922.
  [27] Yoo JJ, Lim YS, Kim MS, et al. Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer[J]. PLoS One, 2020, 15(7):e0236506.
  [28] Fang Z, Xu H, Duan J, et al. Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice[J]. Signal Transduct Target Ther, 2023, 8(1):94.
  [29] Cuzick  J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials[J]. Lancet, 2003, 361(9354):296-300.
  [30] de  Medina P, Paillasse MR, Segala G, et al. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands[J]. Proc Natl Acad Sci USA, 2010, 107(30):13520-13525.
PDF(6687 KB)

Accesses

Citation

Detail

Sections
Recommended

/